Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Icon Plc (ICLR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,314,320
  • Shares Outstanding, K 54,080
  • Annual Sales, $ 1,758 M
  • Annual Income, $ 281,490 K
  • 36-Month Beta 0.67
  • Price/Sales 3.15
  • Price/Cash Flow 20.49
  • Price/Book 5.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.60
  • Number of Estimates 9
  • High Estimate 1.62
  • Low Estimate 1.57
  • Prior Year 1.43
  • Growth Rate Est. (year over year) +11.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
118.10 +14.94%
on 01/03/19
137.80 -1.49%
on 01/16/19
+2.25 (+1.69%)
since 12/14/18
3-Month
118.10 +14.94%
on 01/03/19
149.10 -8.95%
on 10/17/18
-13.41 (-8.99%)
since 10/16/18
52-Week
101.22 +34.11%
on 02/06/18
155.33 -12.61%
on 10/01/18
+23.46 (+20.89%)
since 01/16/18

Most Recent Stories

More News
ICON Issues Financial Guidance for Full Year 2019

--Full Year 2019 Revenue guidance in the range of $2,735 - $2,835 million, representing growth of 5.2 - 9.0%.

ICLR : 134.61 (-1.25%)
AMN or ICLR: Which Is the Better Value Stock Right Now?

AMN vs. ICLR: Which Stock Is the Better Value Option?

AMN : 61.21 (-0.65%)
ICLR : 134.61 (-1.25%)
AMN vs. ICLR: Which Stock Should Value Investors Buy Now?

AMN vs. ICLR: Which Stock Is the Better Value Option?

AMN : 61.21 (-0.65%)
ICLR : 134.61 (-1.25%)
AMN vs. ICLR: Which Stock Should Value Investors Buy Now?

AMN vs. ICLR: Which Stock Is the Better Value Option?

AMN : 61.21 (-0.65%)
ICLR : 134.61 (-1.25%)
Factors of Influence in 2018, Key Indicators and Opportunity within ICON, Robert Half International, CenterPoint Energy, Galapagos NV, Canadian Pacific Railway, and Mobile Mini -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ICON PLC (NASDAQ:ICLR), Robert...

ICLR : 134.61 (-1.25%)
RHI : 58.59 (-0.03%)
MINI : 35.57 (-0.31%)
CNP : 29.35 (+0.20%)
GLPG : 104.46 (+1.43%)
CP : 194.24 (+0.25%)
ICON Wins Pharma Contract Services Company of the Year at the Pharma Industry Awards 2018

ICON plc, (NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded Pharma...

ICLR : 134.61 (-1.25%)
Icon PLC (ICLR) Q3 Earnings Match Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.00% and 0.06%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

ICLR : 134.61 (-1.25%)
Icon PLC: 3Q Earnings Snapshot

DUBLIN (AP) _ Icon PLC (ICLR) on Wednesday reported third-quarter net income of $84.5 million.

ICLR : 134.61 (-1.25%)
ICON Reports Third Quarter 2018 Results

--Excluding the impact of ASC 606, record net business wins in the quarter of $605 million, a book to bill of 1.27.

ICLR : 134.61 (-1.25%)
ICON Announces Release of ADDPLAN(R) neo

(NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology and medical device industries, today announced the release of ADDPLAN(R) neo, providing...

ICLR : 134.61 (-1.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade ICLR with:

Business Summary

ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

See More

Key Turning Points

2nd Resistance Point 138.28
1st Resistance Point 137.30
Last Price 134.61
1st Support Level 134.80
2nd Support Level 133.28

See More

52-Week High 155.33
Fibonacci 61.8% 134.66
Last Price 134.61
Fibonacci 50% 128.27
Fibonacci 38.2% 121.89
52-Week Low 101.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar